AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached herewith Q2FY23 Results presentation of the Company for your records.20-10-2022
20-10-2022
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial Results for the quarter and half year ended September 30, 2022.20-10-2022
AARTI DRUGS LTD. - 524348 - Audited Financial Results For The Quarter And Half Year Ended September 30, 2022
Audited Financial Results for the Quarter and half Year ended September 30, 202220-10-2022
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of Letter of Confirmation in lieu of Duplicate Share Certificate19-10-2022
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call17-10-2022
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Approve And Take On Record Audited Financial Results For The Quarter And Half Year Ended September 30, 2022.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 ,inter alia, to consider and approve Audited Financial Results for the Quarter and half year ended September 30, 202213-10-2022
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for issuance of Letter of Confirmation in lieu of Duplicate Share Certificate11-10-2022
AARTI DRUGS LTD. - 524348 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- Rushikesh DeoleDesignation :- Company Secretary and Compliance Officer10-10-2022
AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201808-10-2022
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Postal Ballot Notice29-09-2022